Advanced Drug Delivery Systems Market, By Type (Oral Drug Delivery System, Injection-Based Drug Delivery System, Inhalation/Pulmonary Drug Delivery System, Transdermal Drug Delivery System, Carrier Based Drug Delivery System, and Others), By Application (
Advanced Drug Delivery Systems Market, By Type (Oral Drug Delivery System, Injection-Based Drug Delivery System, Inhalation/Pulmonary Drug Delivery System, Transdermal Drug Delivery System, Carrier Based Drug Delivery System, and Others), By Application (Cardiovascular Diseases, Oncology, Urology, Ophthalmology, Inflammatory Diseases, and Others), By Carrier Type (Liposomes, Nanoparticles, Microspheres, and Monoclonal Antibodies), By End User (Hospitals, Specialty Clinics, and Others), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa)
Advanced drug delivery systems have enabled the development of novel formulations that can specifically target drugs to areas of the body for localized or sustained treatment. Nanotechnology and other engineering approaches have facilitated the creation of intelligent delivery vehicles like micelles, dendrimers, liposomes, and polymeric nanoparticles that can shield drugs from degradation and control their release. Such delivery platforms help improve the therapeutic index of many drugs by increasing their efficacy and reducing unwanted side effects. With their ability to cross biological barriers and precisely deliver therapeutic payloads, advanced drug delivery systems are revolutionizing the treatment of cancer and other serious diseases.
Market Dynamics:
The advanced drug delivery systems market is driven by the growing demand for targeted and controlled drug delivery. Increasing R&D investments by pharmaceutical companies to develop innovative formulations and the rising prevalence of chronic diseases like cancer are fueling market growth. However, high development costs and regulatory issues pose challenges to new entrants. The untapped potential of emerging economies presents an opportunity for market expansion. Additionally, the growing application scope of advanced delivery technologies like long-acting injectables could open new avenues for drug developers.
Key features of the study:
This report provides in-depth analysis of the global advanced drug delivery systems market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2024–2031), considering 2023 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global advanced drug delivery systems market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Baxter, 3M, Abbott, Dätwyler Holding Inc., Evonik, Astrazeneca, Novo Nordisk A/S, Corium Innovations, Inc., PolyActiva, Teleflex Incorporated, Elixir Medical, B. Braun SE, Nemera, Epion Therapeutics, Inc., Terumo Corporation, and Flowonix Medical Inc
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global advanced drug delivery systems market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global advanced drug delivery systems market
Market Segmentation
Type Insights
Oral Drug Delivery System
Injection-Based Drug Delivery System
Inhalation/Pulmonary Drug Delivery System
Transdermal Drug Delivery System
Carrier Based Drug Delivery System
Others (Transmucosal Drug Delivery System, etc.)
Application Insights
Cardiovascular Diseases
Oncology
Urology
Ophthalmology
Inflammatory Diseases
Others (Infectious Diseases, etc.)
Carrier Type Insights
Liposomes
Nanoparticles
Microspheres
Monoclonal Antibodies
End User Insights
Hospitals
Specialty Clinics
Others (Research Institutes, etc.)
Regional Insights
North America
U.S.
Canada
Latin America
Brazil
Argentina
Mexico
Rest of Latin America
Europe
Germany
U.K.
Spain
France
Italy
Russia
Rest of Europe
Asia Pacific
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
GCC Countries
Israel
Rest of Middle East
Africa
South Africa
North Africa
Central Africa
Key Players Insights
Baxter
3M
Abbott
Dätwyler Holding Inc.
Evonik
Astrazeneca
Novo Nordisk A/S
Corium Innovations, Inc.
PolyActiva
Teleflex Incorporated
Elixir Medical
Braun SE
Nemera
Epion Therapeutics, Inc.
Terumo Corporation
Flowonix Medical Inc
1. Research Objectives and Assumptions
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Advanced Drug Delivery Systems Market, By Type
Advanced Drug Delivery Systems Market, By Application
Advanced Drug Delivery Systems Market, By Carrier Type
Advanced Drug Delivery Systems Market, By End User
Advanced Drug Delivery Systems Market, By Region
3. Market Dynamics, Regulations, And Trends Analysis
Market Dynamics
Impact Analysis
Key Highlights
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER’s Analysis
Merger and Acquisition Scenario
Epidemiology
4. Advanced Drug Delivery Systems Market, By Type, 2019-2031, (USD Bn)
Introduction
Market Share Analysis, 2024 and 2031 (%)
Y-o-Y Growth Analysis, 2020 - 2031
Segment Trends
Oral Drug Delivery System
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Injection-Based Drug Delivery System
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Inhalation/Pulmonary Drug Delivery System
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Transdermal Drug Delivery System
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Carrier Based Drug Delivery System
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others (Transmucosal Drug Delivery System, etc.)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
5. Advanced Drug Delivery Systems Market, By Application, 2019-2031, (USD Bn)
Introduction
Market Share Analysis, 2024 and 2031 (%)
Y-o-Y Growth Analysis, 2020 - 2031
Segment Trends
Cardiovascular Diseases
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Oncology
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Urology
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Ophthalmology
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Inflammatory Diseases
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others (Infectious Diseases, etc.)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
6. Advanced Drug Delivery Systems Market, By Carrier Type, 2019-2031, (USD Bn)
Introduction
Market Share Analysis, 2024 and 2031 (%)
Y-o-Y Growth Analysis, 2020 - 2031
Segment Trends
Liposomes
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Nanoparticles
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Microspheres
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Monoclonal Antibodies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
7. Advanced Drug Delivery Systems Market, By End User, 2019-2031, (USD Bn)
Introduction
Market Share Analysis, 2024 and 2031 (%)
Y-o-Y Growth Analysis, 2020 - 2031
Segment Trends
Hospitals
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Specialty Clinics
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others (Research Institutes, etc.)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
8. Global Advanced Drug Delivery Systems Market, By Region, 2019 - 2031, Value (USD Bn)
Introduction
Market Share (%) Analysis, 2024,2027 & 2031, Value (USD Bn)